↓ Skip to main content

The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre

Overview of attention for article published in European Journal of Cancer (1965), September 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
2 news outlets
policy
1 policy source
twitter
6 X users

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
146 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre
Published in
European Journal of Cancer (1965), September 2014
DOI 10.1016/j.ejca.2014.08.002
Pubmed ID
Authors

Terri Patricia McVeigh, Lauren M. Hughes, Nicola Miller, Margaret Sheehan, Maccon Keane, Karl J. Sweeney, Michael J. Kerin

Abstract

The use of chemotherapy in node-negative, (O)Estrogen Receptor (ER)-positive breast cancer has changed significantly since the introduction of Oncotype DX to determine systemic recurrence risk based on tumour genomic signature.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 146 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 <1%
Spain 1 <1%
Unknown 144 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 32 22%
Student > Master 21 14%
Student > Ph. D. Student 17 12%
Researcher 13 9%
Other 12 8%
Other 26 18%
Unknown 25 17%
Readers by discipline Count As %
Medicine and Dentistry 45 31%
Biochemistry, Genetics and Molecular Biology 18 12%
Agricultural and Biological Sciences 17 12%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Nursing and Health Professions 4 3%
Other 23 16%
Unknown 34 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2021.
All research outputs
#1,590,538
of 25,394,764 outputs
Outputs from European Journal of Cancer (1965)
#324
of 6,872 outputs
Outputs of similar age
#16,808
of 258,775 outputs
Outputs of similar age from European Journal of Cancer (1965)
#2
of 64 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,872 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,775 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.